Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Nitric Oxide in Pediatric Cardiopulmonary Bypass
NCT00585013Phase 2Completed
- Sponsor
- Washington University School of Medicine
- Start
- Jan 2008
- Primary completion
- Jun 2011
- Modality
- DNA Intercalators/Alkylators, Inhalation Devices
- Countries
- 1
01
Overview
A Phase 2 trial of nitric oxide in congenital heart disease (CHD), sponsored by Washington University School of Medicine. Started Jan 2008; status: completed.
02
Drugs
nitric oxide
03
Conditions
congenital heart disease (CHD)
Beyond the preview
Go deeper on NCT00585013.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00585013.